Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Ropivacaine Market Growth 2022-2028

  • LP 4832856
  • 129 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Ropivacaine will have significant change from previous year. According to our (LP Information) latest study, the global Ropivacaine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Ropivacaine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Ropivacaine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ropivacaine market, reaching US$ million by the year 2028. As for the Europe Ropivacaine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Ropivacaine players cover AstraZeneca, Aspen Pharmacare, Celgene, and Taiwan Liposome Company, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Ropivacaine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Lumbar Epidural Administration

Thoracic Epidural Administration

Regional Block

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Anesthesia

Systemic Neuropathic Pain

Postherpes Pain

Post-Operative Pain

Surgical Analgesia

Labor Analgesia

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AstraZeneca

Aspen Pharmacare

Celgene

Taiwan Liposome Company

Nuvo Pharmaceuticals

Heron Therapeutics

Encore Therapeutics

PainReform Ltd

Anhui Wellman Pharmaceutical

Yichang Renfu Pharmaceutical

Shandong New Era Pharmaceutical

Shanxi Pude Pharmaceutical

Guangdong Huarun Shunfeng Pharmaceutical

Guangdong Jiabo Pharmaceutical

Chengdu Tiantaishan Pharmaceutical

Yangtze Pharmaceutical Group

Jiangsu Hengrui Pharmaceutical

Jiangsu Enhua Pharmaceutical

Hebei Yipin Pharmaceutical

Zhejiang Xianju Pharmaceutical

Hainan Sida Pharmaceutical

Xi'an Hanfeng Pharmaceutical

Chenxin Pharmaceutical

Shaanxi Bosen Biopharmaceutical

Qilu Pharmaceutical

Shenyang Sansheng Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ropivacaine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Ropivacaine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Ropivacaine by Country/Region, 2017, 2022 & 2028

2.2 Ropivacaine Segment by Type

2.2.1 Lumbar Epidural Administration

2.2.2 Thoracic Epidural Administration

2.2.3 Regional Block

2.3 Ropivacaine Sales by Type

2.3.1 Global Ropivacaine Sales Market Share by Type (2017-2022)

2.3.2 Global Ropivacaine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Ropivacaine Sale Price by Type (2017-2022)

2.4 Ropivacaine Segment by Application

2.4.1 Anesthesia

2.4.2 Systemic Neuropathic Pain

2.4.3 Postherpes Pain

2.4.4 Post-Operative Pain

2.4.5 Surgical Analgesia

2.4.6 Labor Analgesia

2.4.7 Other

2.5 Ropivacaine Sales by Application

2.5.1 Global Ropivacaine Sale Market Share by Application (2017-2022)

2.5.2 Global Ropivacaine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Ropivacaine Sale Price by Application (2017-2022)

3 Global Ropivacaine by Company

3.1 Global Ropivacaine Breakdown Data by Company

3.1.1 Global Ropivacaine Annual Sales by Company (2020-2022)

3.1.2 Global Ropivacaine Sales Market Share by Company (2020-2022)

3.2 Global Ropivacaine Annual Revenue by Company (2020-2022)

3.2.1 Global Ropivacaine Revenue by Company (2020-2022)

3.2.2 Global Ropivacaine Revenue Market Share by Company (2020-2022)

3.3 Global Ropivacaine Sale Price by Company

3.4 Key Manufacturers Ropivacaine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Ropivacaine Product Location Distribution

3.4.2 Players Ropivacaine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Ropivacaine by Geographic Region

4.1 World Historic Ropivacaine Market Size by Geographic Region (2017-2022)

4.1.1 Global Ropivacaine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Ropivacaine Annual Revenue by Geographic Region

4.2 World Historic Ropivacaine Market Size by Country/Region (2017-2022)

4.2.1 Global Ropivacaine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Ropivacaine Annual Revenue by Country/Region

4.3 Americas Ropivacaine Sales Growth

4.4 APAC Ropivacaine Sales Growth

4.5 Europe Ropivacaine Sales Growth

4.6 Middle East & Africa Ropivacaine Sales Growth

5 Americas

5.1 Americas Ropivacaine Sales by Country

5.1.1 Americas Ropivacaine Sales by Country (2017-2022)

5.1.2 Americas Ropivacaine Revenue by Country (2017-2022)

5.2 Americas Ropivacaine Sales by Type

5.3 Americas Ropivacaine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Ropivacaine Sales by Region

6.1.1 APAC Ropivacaine Sales by Region (2017-2022)

6.1.2 APAC Ropivacaine Revenue by Region (2017-2022)

6.2 APAC Ropivacaine Sales by Type

6.3 APAC Ropivacaine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Ropivacaine by Country

7.1.1 Europe Ropivacaine Sales by Country (2017-2022)

7.1.2 Europe Ropivacaine Revenue by Country (2017-2022)

7.2 Europe Ropivacaine Sales by Type

7.3 Europe Ropivacaine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Ropivacaine by Country

8.1.1 Middle East & Africa Ropivacaine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Ropivacaine Revenue by Country (2017-2022)

8.2 Middle East & Africa Ropivacaine Sales by Type

8.3 Middle East & Africa Ropivacaine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Ropivacaine

10.3 Manufacturing Process Analysis of Ropivacaine

10.4 Industry Chain Structure of Ropivacaine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Ropivacaine Distributors

11.3 Ropivacaine Customer

12 World Forecast Review for Ropivacaine by Geographic Region

12.1 Global Ropivacaine Market Size Forecast by Region

12.1.1 Global Ropivacaine Forecast by Region (2023-2028)

12.1.2 Global Ropivacaine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Ropivacaine Forecast by Type

12.7 Global Ropivacaine Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca

13.1.1 AstraZeneca Company Information

13.1.2 AstraZeneca Ropivacaine Product Offered

13.1.3 AstraZeneca Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Main Business Overview

13.1.5 AstraZeneca Latest Developments

13.2 Aspen Pharmacare

13.2.1 Aspen Pharmacare Company Information

13.2.2 Aspen Pharmacare Ropivacaine Product Offered

13.2.3 Aspen Pharmacare Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Aspen Pharmacare Main Business Overview

13.2.5 Aspen Pharmacare Latest Developments

13.3 Celgene

13.3.1 Celgene Company Information

13.3.2 Celgene Ropivacaine Product Offered

13.3.3 Celgene Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Celgene Main Business Overview

13.3.5 Celgene Latest Developments

13.4 Taiwan Liposome Company

13.4.1 Taiwan Liposome Company Company Information

13.4.2 Taiwan Liposome Company Ropivacaine Product Offered

13.4.3 Taiwan Liposome Company Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Taiwan Liposome Company Main Business Overview

13.4.5 Taiwan Liposome Company Latest Developments

13.5 Nuvo Pharmaceuticals

13.5.1 Nuvo Pharmaceuticals Company Information

13.5.2 Nuvo Pharmaceuticals Ropivacaine Product Offered

13.5.3 Nuvo Pharmaceuticals Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Nuvo Pharmaceuticals Main Business Overview

13.5.5 Nuvo Pharmaceuticals Latest Developments

13.6 Heron Therapeutics

13.6.1 Heron Therapeutics Company Information

13.6.2 Heron Therapeutics Ropivacaine Product Offered

13.6.3 Heron Therapeutics Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Heron Therapeutics Main Business Overview

13.6.5 Heron Therapeutics Latest Developments

13.7 Encore Therapeutics

13.7.1 Encore Therapeutics Company Information

13.7.2 Encore Therapeutics Ropivacaine Product Offered

13.7.3 Encore Therapeutics Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Encore Therapeutics Main Business Overview

13.7.5 Encore Therapeutics Latest Developments

13.8 PainReform Ltd

13.8.1 PainReform Ltd Company Information

13.8.2 PainReform Ltd Ropivacaine Product Offered

13.8.3 PainReform Ltd Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 PainReform Ltd Main Business Overview

13.8.5 PainReform Ltd Latest Developments

13.9 Anhui Wellman Pharmaceutical

13.9.1 Anhui Wellman Pharmaceutical Company Information

13.9.2 Anhui Wellman Pharmaceutical Ropivacaine Product Offered

13.9.3 Anhui Wellman Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Anhui Wellman Pharmaceutical Main Business Overview

13.9.5 Anhui Wellman Pharmaceutical Latest Developments

13.10 Yichang Renfu Pharmaceutical

13.10.1 Yichang Renfu Pharmaceutical Company Information

13.10.2 Yichang Renfu Pharmaceutical Ropivacaine Product Offered

13.10.3 Yichang Renfu Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Yichang Renfu Pharmaceutical Main Business Overview

13.10.5 Yichang Renfu Pharmaceutical Latest Developments

13.11 Shandong New Era Pharmaceutical

13.11.1 Shandong New Era Pharmaceutical Company Information

13.11.2 Shandong New Era Pharmaceutical Ropivacaine Product Offered

13.11.3 Shandong New Era Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Shandong New Era Pharmaceutical Main Business Overview

13.11.5 Shandong New Era Pharmaceutical Latest Developments

13.12 Shanxi Pude Pharmaceutical

13.12.1 Shanxi Pude Pharmaceutical Company Information

13.12.2 Shanxi Pude Pharmaceutical Ropivacaine Product Offered

13.12.3 Shanxi Pude Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Shanxi Pude Pharmaceutical Main Business Overview

13.12.5 Shanxi Pude Pharmaceutical Latest Developments

13.13 Guangdong Huarun Shunfeng Pharmaceutical

13.13.1 Guangdong Huarun Shunfeng Pharmaceutical Company Information

13.13.2 Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Product Offered

13.13.3 Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Guangdong Huarun Shunfeng Pharmaceutical Main Business Overview

13.13.5 Guangdong Huarun Shunfeng Pharmaceutical Latest Developments

13.14 Guangdong Jiabo Pharmaceutical

13.14.1 Guangdong Jiabo Pharmaceutical Company Information

13.14.2 Guangdong Jiabo Pharmaceutical Ropivacaine Product Offered

13.14.3 Guangdong Jiabo Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Guangdong Jiabo Pharmaceutical Main Business Overview

13.14.5 Guangdong Jiabo Pharmaceutical Latest Developments

13.15 Chengdu Tiantaishan Pharmaceutical

13.15.1 Chengdu Tiantaishan Pharmaceutical Company Information

13.15.2 Chengdu Tiantaishan Pharmaceutical Ropivacaine Product Offered

13.15.3 Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Chengdu Tiantaishan Pharmaceutical Main Business Overview

13.15.5 Chengdu Tiantaishan Pharmaceutical Latest Developments

13.16 Yangtze Pharmaceutical Group

13.16.1 Yangtze Pharmaceutical Group Company Information

13.16.2 Yangtze Pharmaceutical Group Ropivacaine Product Offered

13.16.3 Yangtze Pharmaceutical Group Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Yangtze Pharmaceutical Group Main Business Overview

13.16.5 Yangtze Pharmaceutical Group Latest Developments

13.17 Jiangsu Hengrui Pharmaceutical

13.17.1 Jiangsu Hengrui Pharmaceutical Company Information

13.17.2 Jiangsu Hengrui Pharmaceutical Ropivacaine Product Offered

13.17.3 Jiangsu Hengrui Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Jiangsu Hengrui Pharmaceutical Main Business Overview

13.17.5 Jiangsu Hengrui Pharmaceutical Latest Developments

13.18 Jiangsu Enhua Pharmaceutical

13.18.1 Jiangsu Enhua Pharmaceutical Company Information

13.18.2 Jiangsu Enhua Pharmaceutical Ropivacaine Product Offered

13.18.3 Jiangsu Enhua Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Jiangsu Enhua Pharmaceutical Main Business Overview

13.18.5 Jiangsu Enhua Pharmaceutical Latest Developments

13.19 Hebei Yipin Pharmaceutical

13.19.1 Hebei Yipin Pharmaceutical Company Information

13.19.2 Hebei Yipin Pharmaceutical Ropivacaine Product Offered

13.19.3 Hebei Yipin Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Hebei Yipin Pharmaceutical Main Business Overview

13.19.5 Hebei Yipin Pharmaceutical Latest Developments

13.20 Zhejiang Xianju Pharmaceutical

13.20.1 Zhejiang Xianju Pharmaceutical Company Information

13.20.2 Zhejiang Xianju Pharmaceutical Ropivacaine Product Offered

13.20.3 Zhejiang Xianju Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Zhejiang Xianju Pharmaceutical Main Business Overview

13.20.5 Zhejiang Xianju Pharmaceutical Latest Developments

13.21 Hainan Sida Pharmaceutical

13.21.1 Hainan Sida Pharmaceutical Company Information

13.21.2 Hainan Sida Pharmaceutical Ropivacaine Product Offered

13.21.3 Hainan Sida Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Hainan Sida Pharmaceutical Main Business Overview

13.21.5 Hainan Sida Pharmaceutical Latest Developments

13.22 Xi'an Hanfeng Pharmaceutical

13.22.1 Xi'an Hanfeng Pharmaceutical Company Information

13.22.2 Xi'an Hanfeng Pharmaceutical Ropivacaine Product Offered

13.22.3 Xi'an Hanfeng Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Xi'an Hanfeng Pharmaceutical Main Business Overview

13.22.5 Xi'an Hanfeng Pharmaceutical Latest Developments

13.23 Chenxin Pharmaceutical

13.23.1 Chenxin Pharmaceutical Company Information

13.23.2 Chenxin Pharmaceutical Ropivacaine Product Offered

13.23.3 Chenxin Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Chenxin Pharmaceutical Main Business Overview

13.23.5 Chenxin Pharmaceutical Latest Developments

13.24 Shaanxi Bosen Biopharmaceutical

13.24.1 Shaanxi Bosen Biopharmaceutical Company Information

13.24.2 Shaanxi Bosen Biopharmaceutical Ropivacaine Product Offered

13.24.3 Shaanxi Bosen Biopharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Shaanxi Bosen Biopharmaceutical Main Business Overview

13.24.5 Shaanxi Bosen Biopharmaceutical Latest Developments

13.25 Qilu Pharmaceutical

13.25.1 Qilu Pharmaceutical Company Information

13.25.2 Qilu Pharmaceutical Ropivacaine Product Offered

13.25.3 Qilu Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Qilu Pharmaceutical Main Business Overview

13.25.5 Qilu Pharmaceutical Latest Developments

13.26 Shenyang Sansheng Pharmaceutical

13.26.1 Shenyang Sansheng Pharmaceutical Company Information

13.26.2 Shenyang Sansheng Pharmaceutical Ropivacaine Product Offered

13.26.3 Shenyang Sansheng Pharmaceutical Ropivacaine Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Shenyang Sansheng Pharmaceutical Main Business Overview

13.26.5 Shenyang Sansheng Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Ropivacaine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Ropivacaine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Lumbar Epidural Administration

Table 4. Major Players of Thoracic Epidural Administration

Table 5. Major Players of Regional Block

Table 6. Global Ropivacaine Sales by Type (2017-2022) & (K Doses)

Table 7. Global Ropivacaine Sales Market Share by Type (2017-2022)

Table 8. Global Ropivacaine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Ropivacaine Revenue Market Share by Type (2017-2022)

Table 10. Global Ropivacaine Sale Price by Type (2017-2022) & (US$/Dose)

Table 11. Global Ropivacaine Sales by Application (2017-2022) & (K Doses)

Table 12. Global Ropivacaine Sales Market Share by Application (2017-2022)

Table 13. Global Ropivacaine Revenue by Application (2017-2022)

Table 14. Global Ropivacaine Revenue Market Share by Application (2017-2022)

Table 15. Global Ropivacaine Sale Price by Application (2017-2022) & (US$/Dose)

Table 16. Global Ropivacaine Sales by Company (2020-2022) & (K Doses)

Table 17. Global Ropivacaine Sales Market Share by Company (2020-2022)

Table 18. Global Ropivacaine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Ropivacaine Revenue Market Share by Company (2020-2022)

Table 20. Global Ropivacaine Sale Price by Company (2020-2022) & (US$/Dose)

Table 21. Key Manufacturers Ropivacaine Producing Area Distribution and Sales Area

Table 22. Players Ropivacaine Products Offered

Table 23. Ropivacaine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Ropivacaine Sales by Geographic Region (2017-2022) & (K Doses)

Table 27. Global Ropivacaine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Ropivacaine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Ropivacaine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Ropivacaine Sales by Country/Region (2017-2022) & (K Doses)

Table 31. Global Ropivacaine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Ropivacaine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Ropivacaine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Ropivacaine Sales by Country (2017-2022) & (K Doses)

Table 35. Americas Ropivacaine Sales Market Share by Country (2017-2022)

Table 36. Americas Ropivacaine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Ropivacaine Revenue Market Share by Country (2017-2022)

Table 38. Americas Ropivacaine Sales by Type (2017-2022) & (K Doses)

Table 39. Americas Ropivacaine Sales Market Share by Type (2017-2022)

Table 40. Americas Ropivacaine Sales by Application (2017-2022) & (K Doses)

Table 41. Americas Ropivacaine Sales Market Share by Application (2017-2022)

Table 42. APAC Ropivacaine Sales by Region (2017-2022) & (K Doses)

Table 43. APAC Ropivacaine Sales Market Share by Region (2017-2022)

Table 44. APAC Ropivacaine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Ropivacaine Revenue Market Share by Region (2017-2022)

Table 46. APAC Ropivacaine Sales by Type (2017-2022) & (K Doses)

Table 47. APAC Ropivacaine Sales Market Share by Type (2017-2022)

Table 48. APAC Ropivacaine Sales by Application (2017-2022) & (K Doses)

Table 49. APAC Ropivacaine Sales Market Share by Application (2017-2022)

Table 50. Europe Ropivacaine Sales by Country (2017-2022) & (K Doses)

Table 51. Europe Ropivacaine Sales Market Share by Country (2017-2022)

Table 52. Europe Ropivacaine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Ropivacaine Revenue Market Share by Country (2017-2022)

Table 54. Europe Ropivacaine Sales by Type (2017-2022) & (K Doses)

Table 55. Europe Ropivacaine Sales Market Share by Type (2017-2022)

Table 56. Europe Ropivacaine Sales by Application (2017-2022) & (K Doses)

Table 57. Europe Ropivacaine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Ropivacaine Sales by Country (2017-2022) & (K Doses)

Table 59. Middle East & Africa Ropivacaine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Ropivacaine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Ropivacaine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Ropivacaine Sales by Type (2017-2022) & (K Doses)

Table 63. Middle East & Africa Ropivacaine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Ropivacaine Sales by Application (2017-2022) & (K Doses)

Table 65. Middle East & Africa Ropivacaine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Ropivacaine

Table 67. Key Market Challenges & Risks of Ropivacaine

Table 68. Key Industry Trends of Ropivacaine

Table 69. Ropivacaine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Ropivacaine Distributors List

Table 72. Ropivacaine Customer List

Table 73. Global Ropivacaine Sales Forecast by Region (2023-2028) & (K Doses)

Table 74. Global Ropivacaine Sales Market Forecast by Region

Table 75. Global Ropivacaine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Ropivacaine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Ropivacaine Sales Forecast by Country (2023-2028) & (K Doses)

Table 78. Americas Ropivacaine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Ropivacaine Sales Forecast by Region (2023-2028) & (K Doses)

Table 80. APAC Ropivacaine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Ropivacaine Sales Forecast by Country (2023-2028) & (K Doses)

Table 82. Europe Ropivacaine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Ropivacaine Sales Forecast by Country (2023-2028) & (K Doses)

Table 84. Middle East & Africa Ropivacaine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Ropivacaine Sales Forecast by Type (2023-2028) & (K Doses)

Table 86. Global Ropivacaine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Ropivacaine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Ropivacaine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Ropivacaine Sales Forecast by Application (2023-2028) & (K Doses)

Table 90. Global Ropivacaine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Ropivacaine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Ropivacaine Revenue Market Share Forecast by Application (2023-2028)

Table 93. AstraZeneca Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 94. AstraZeneca Ropivacaine Product Offered

Table 95. AstraZeneca Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 96. AstraZeneca Main Business

Table 97. AstraZeneca Latest Developments

Table 98. Aspen Pharmacare Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 99. Aspen Pharmacare Ropivacaine Product Offered

Table 100. Aspen Pharmacare Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 101. Aspen Pharmacare Main Business

Table 102. Aspen Pharmacare Latest Developments

Table 103. Celgene Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 104. Celgene Ropivacaine Product Offered

Table 105. Celgene Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 106. Celgene Main Business

Table 107. Celgene Latest Developments

Table 108. Taiwan Liposome Company Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 109. Taiwan Liposome Company Ropivacaine Product Offered

Table 110. Taiwan Liposome Company Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 111. Taiwan Liposome Company Main Business

Table 112. Taiwan Liposome Company Latest Developments

Table 113. Nuvo Pharmaceuticals Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 114. Nuvo Pharmaceuticals Ropivacaine Product Offered

Table 115. Nuvo Pharmaceuticals Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 116. Nuvo Pharmaceuticals Main Business

Table 117. Nuvo Pharmaceuticals Latest Developments

Table 118. Heron Therapeutics Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 119. Heron Therapeutics Ropivacaine Product Offered

Table 120. Heron Therapeutics Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 121. Heron Therapeutics Main Business

Table 122. Heron Therapeutics Latest Developments

Table 123. Encore Therapeutics Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 124. Encore Therapeutics Ropivacaine Product Offered

Table 125. Encore Therapeutics Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 126. Encore Therapeutics Main Business

Table 127. Encore Therapeutics Latest Developments

Table 128. PainReform Ltd Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 129. PainReform Ltd Ropivacaine Product Offered

Table 130. PainReform Ltd Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 131. PainReform Ltd Main Business

Table 132. PainReform Ltd Latest Developments

Table 133. Anhui Wellman Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 134. Anhui Wellman Pharmaceutical Ropivacaine Product Offered

Table 135. Anhui Wellman Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 136. Anhui Wellman Pharmaceutical Main Business

Table 137. Anhui Wellman Pharmaceutical Latest Developments

Table 138. Yichang Renfu Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 139. Yichang Renfu Pharmaceutical Ropivacaine Product Offered

Table 140. Yichang Renfu Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 141. Yichang Renfu Pharmaceutical Main Business

Table 142. Yichang Renfu Pharmaceutical Latest Developments

Table 143. Shandong New Era Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 144. Shandong New Era Pharmaceutical Ropivacaine Product Offered

Table 145. Shandong New Era Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 146. Shandong New Era Pharmaceutical Main Business

Table 147. Shandong New Era Pharmaceutical Latest Developments

Table 148. Shanxi Pude Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 149. Shanxi Pude Pharmaceutical Ropivacaine Product Offered

Table 150. Shanxi Pude Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 151. Shanxi Pude Pharmaceutical Main Business

Table 152. Shanxi Pude Pharmaceutical Latest Developments

Table 153. Guangdong Huarun Shunfeng Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 154. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Product Offered

Table 155. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 156. Guangdong Huarun Shunfeng Pharmaceutical Main Business

Table 157. Guangdong Huarun Shunfeng Pharmaceutical Latest Developments

Table 158. Guangdong Jiabo Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 159. Guangdong Jiabo Pharmaceutical Ropivacaine Product Offered

Table 160. Guangdong Jiabo Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 161. Guangdong Jiabo Pharmaceutical Main Business

Table 162. Guangdong Jiabo Pharmaceutical Latest Developments

Table 163. Chengdu Tiantaishan Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 164. Chengdu Tiantaishan Pharmaceutical Ropivacaine Product Offered

Table 165. Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 166. Chengdu Tiantaishan Pharmaceutical Main Business

Table 167. Chengdu Tiantaishan Pharmaceutical Latest Developments

Table 168. Yangtze Pharmaceutical Group Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 169. Yangtze Pharmaceutical Group Ropivacaine Product Offered

Table 170. Yangtze Pharmaceutical Group Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 171. Yangtze Pharmaceutical Group Main Business

Table 172. Yangtze Pharmaceutical Group Latest Developments

Table 173. Jiangsu Hengrui Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 174. Jiangsu Hengrui Pharmaceutical Ropivacaine Product Offered

Table 175. Jiangsu Hengrui Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 176. Jiangsu Hengrui Pharmaceutical Main Business

Table 177. Jiangsu Hengrui Pharmaceutical Latest Developments

Table 178. Jiangsu Enhua Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 179. Jiangsu Enhua Pharmaceutical Ropivacaine Product Offered

Table 180. Jiangsu Enhua Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 181. Jiangsu Enhua Pharmaceutical Main Business

Table 182. Jiangsu Enhua Pharmaceutical Latest Developments

Table 183. Hebei Yipin Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 184. Hebei Yipin Pharmaceutical Ropivacaine Product Offered

Table 185. Hebei Yipin Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 186. Hebei Yipin Pharmaceutical Main Business

Table 187. Hebei Yipin Pharmaceutical Latest Developments

Table 188. Zhejiang Xianju Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 189. Zhejiang Xianju Pharmaceutical Ropivacaine Product Offered

Table 190. Zhejiang Xianju Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 191. Zhejiang Xianju Pharmaceutical Main Business

Table 192. Zhejiang Xianju Pharmaceutical Latest Developments

Table 193. Hainan Sida Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 194. Hainan Sida Pharmaceutical Ropivacaine Product Offered

Table 195. Hainan Sida Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 196. Hainan Sida Pharmaceutical Main Business

Table 197. Hainan Sida Pharmaceutical Latest Developments

Table 198. Xi'an Hanfeng Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 199. Xi'an Hanfeng Pharmaceutical Ropivacaine Product Offered

Table 200. Xi'an Hanfeng Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 201. Xi'an Hanfeng Pharmaceutical Main Business

Table 202. Xi'an Hanfeng Pharmaceutical Latest Developments

Table 203. Chenxin Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 204. Chenxin Pharmaceutical Ropivacaine Product Offered

Table 205. Chenxin Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 206. Chenxin Pharmaceutical Main Business

Table 207. Chenxin Pharmaceutical Latest Developments

Table 208. Shaanxi Bosen Biopharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 209. Shaanxi Bosen Biopharmaceutical Ropivacaine Product Offered

Table 210. Shaanxi Bosen Biopharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 211. Shaanxi Bosen Biopharmaceutical Main Business

Table 212. Shaanxi Bosen Biopharmaceutical Latest Developments

Table 213. Qilu Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 214. Qilu Pharmaceutical Ropivacaine Product Offered

Table 215. Qilu Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 216. Qilu Pharmaceutical Main Business

Table 217. Qilu Pharmaceutical Latest Developments

Table 218. Shenyang Sansheng Pharmaceutical Basic Information, Ropivacaine Manufacturing Base, Sales Area and Its Competitors

Table 219. Shenyang Sansheng Pharmaceutical Ropivacaine Product Offered

Table 220. Shenyang Sansheng Pharmaceutical Ropivacaine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 221. Shenyang Sansheng Pharmaceutical Main Business

Table 222. Shenyang Sansheng Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Ropivacaine

Figure 2. Ropivacaine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Ropivacaine Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Ropivacaine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Ropivacaine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Lumbar Epidural Administration

Figure 10. Product Picture of Thoracic Epidural Administration

Figure 11. Product Picture of Regional Block

Figure 12. Global Ropivacaine Sales Market Share by Type in 2021

Figure 13. Global Ropivacaine Revenue Market Share by Type (2017-2022)

Figure 14. Ropivacaine Consumed in Anesthesia

Figure 15. Global Ropivacaine Market: Anesthesia (2017-2022) & (K Doses)

Figure 16. Ropivacaine Consumed in Systemic Neuropathic Pain

Figure 17. Global Ropivacaine Market: Systemic Neuropathic Pain (2017-2022) & (K Doses)

Figure 18. Ropivacaine Consumed in Postherpes Pain

Figure 19. Global Ropivacaine Market: Postherpes Pain (2017-2022) & (K Doses)

Figure 20. Ropivacaine Consumed in Post-Operative Pain

Figure 21. Global Ropivacaine Market: Post-Operative Pain (2017-2022) & (K Doses)

Figure 22. Ropivacaine Consumed in Surgical Analgesia

Figure 23. Global Ropivacaine Market: Surgical Analgesia (2017-2022) & (K Doses)

Figure 24. Ropivacaine Consumed in Labor Analgesia

Figure 25. Global Ropivacaine Market: Labor Analgesia (2017-2022) & (K Doses)

Figure 26. Ropivacaine Consumed in Other

Figure 27. Global Ropivacaine Market: Other (2017-2022) & (K Doses)

Figure 28. Global Ropivacaine Sales Market Share by Application (2017-2022)

Figure 29. Global Ropivacaine Revenue Market Share by Application in 2021

Figure 30. Ropivacaine Revenue Market by Company in 2021 ($ Million)

Figure 31. Global Ropivacaine Revenue Market Share by Company in 2021

Figure 32. Global Ropivacaine Sales Market Share by Geographic Region (2017-2022)

Figure 33. Global Ropivacaine Revenue Market Share by Geographic Region in 2021

Figure 34. Global Ropivacaine Sales Market Share by Region (2017-2022)

Figure 35. Global Ropivacaine Revenue Market Share by Country/Region in 2021

Figure 36. Americas Ropivacaine Sales 2017-2022 (K Doses)

Figure 37. Americas Ropivacaine Revenue 2017-2022 ($ Millions)

Figure 38. APAC Ropivacaine Sales 2017-2022 (K Doses)

Figure 39. APAC Ropivacaine Revenue 2017-2022 ($ Millions)

Figure 40. Europe Ropivacaine Sales 2017-2022 (K Doses)

Figure 41. Europe Ropivacaine Revenue 2017-2022 ($ Millions)

Figure 42. Middle East & Africa Ropivacaine Sales 2017-2022 (K Doses)

Figure 43. Middle East & Africa Ropivacaine Revenue 2017-2022 ($ Millions)

Figure 44. Americas Ropivacaine Sales Market Share by Country in 2021

Figure 45. Americas Ropivacaine Revenue Market Share by Country in 2021

Figure 46. United States Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Canada Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Mexico Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Brazil Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 50. APAC Ropivacaine Sales Market Share by Region in 2021

Figure 51. APAC Ropivacaine Revenue Market Share by Regions in 2021

Figure 52. China Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Japan Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 54. South Korea Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Southeast Asia Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 56. India Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Australia Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Europe Ropivacaine Sales Market Share by Country in 2021

Figure 59. Europe Ropivacaine Revenue Market Share by Country in 2021

Figure 60. Germany Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 61. France Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 62. UK Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Italy Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 64. Russia Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Middle East & Africa Ropivacaine Sales Market Share by Country in 2021

Figure 66. Middle East & Africa Ropivacaine Revenue Market Share by Country in 2021

Figure 67. Egypt Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 68. South Africa Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 69. Israel Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 70. Turkey Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 71. GCC Country Ropivacaine Revenue Growth 2017-2022 ($ Millions)

Figure 72. Manufacturing Cost Structure Analysis of Ropivacaine in 2021

Figure 73. Manufacturing Process Analysis of Ropivacaine

Figure 74. Industry Chain Structure of Ropivacaine

Figure 75. Channels of Distribution

Figure 76. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390